Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazole and recombinant human granulocyte-colony stimulating factor
✍ Scribed by HIROYUKI SHICHINO; HIDEO MUGISHIMA; MAYUMI TAKAMURA; TOSHIAKI SHIMADA; TAKASHI SUZUKI; MOTOAKI CHIN; KENSUKE HARADA; SIGEO RYO; SEIJI KOJIMA
- Book ID
- 115176935
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 342 KB
- Volume
- 38
- Category
- Article
- ISSN
- 1328-8067
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients
To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti